Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15848669 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
Conditions: Liver Disease;   Liver Transplantation
Interventions: Drug: Alemtuzumab;   Drug: Cyclosporine;   Drug: Mycophenolate mofetil;   Drug: Tacrolimus;   Procedure: Liver transplant;   Procedure: Immunosuppression withdrawal

Indicates status has not been verified in more than two years